Clean Science & Technology Ltd

- No mention of any current or future fundraising through debt or equity in the call. - The company’s balance sheet remains debt-free with a cash balance of approximately INR 300 crores. - All capex continues to be funded through internal accruals only. - For FY '24, capex guidance is around INR 180 crores primarily for HALS and infrastructure at the subsidiary. - Additional incremental capex (around INR 200 crores) for new products is expected in FY '25. - No indication from management of plans to raise external debt or equity for these capex requirements.

- FY '23 capex was INR 191-193 crores, the highest in company history, majorly for new HALS plants (Unit 3) and efficiency upgrades. - FY '24 capex guidance is around INR 180 crores, largely towards commissioning HALS plants in subsidiary (Unit 4) and associated site development (utilities, infra). - Additional capex of approximately INR 200 crores planned for new performance chemicals and other products, expected to start construction mid-2023 with commercialization by mid-FY '25. - Total capacity expansion targeting 15,000 tons for HALS products over 3-4 years, with overall INR 300 crores capex including site development. - Capex includes investments in clean energy (solar plants totaling 17.4 MW) and sustainability initiatives. - All capex funded through internal accruals; company remains debt-free with strong financials. - New facilities aim to drive revenue diversification and growth, especially from HALS and new performance chemical products.

- FY '24 revenues expected largely from existing product basket; new products (HALS) to start contributing significantly from mid-FY '25 and ramp up over next 3 years. - Commissioned HALS plants (770 and 701) with 2,000 tons per annum capacity will contribute additional revenue in FY '24; total HALS capacity expected to reach 15,000 tons with expansions. - Additional capex of INR 200 crores targeted for new products starting construction mid-2023, with production beginning mid-FY '25. - Volume growth expected to recover in Q2/Q3 FY '24 after destocking phase in Q1. - Existing product capacities (MEHQ, BHA) have leeway for growth and potential capacity replication. - Export markets growth aligned with domestic trends, affected by global demand cycles but expected to sustain over medium term. - Volume growth remains a key driver despite raw material price volatility and competitiveness.

- FY '24 revenues largely from existing products; new HALS products to contribute significantly from FY '25 onwards. - Incremental capex of INR 200 crores planned mainly in FY '24 and FY '25 for new products, expected to drive growth. - HALS capacity expansions (770 and 701 units) already adding in FY '24; further ramps over next 3 years. - New products expected to have initially lower margins but target 2x ROC and margins comparable to parent company as utilization increases. - Margin guidance for parent company steady; subsidiary margins expected to improve with higher utilization. - Moderate demand volatility expected; growth driven by volume rather than pricing or currency tailwinds seen in FY '23. - Company aims for sustained top-line and profit growth driven by diversification, new products, and export expansion. - ROCE around 50% targeted long term on newer products with better asset turns planned.

The transcript does not explicitly mention the current or expected order book or pending orders for Clean Science and Technology Limited. However, insights related to demand and production include: - HALS product commercialization targeting 100 tons per month after one year of production, aiming for around 30% market share in the Indian market. - New HALS products capacity ramp-up: 15,000 tons total, partially commissioned in FY '24. - New product launches expected to start contributing from mid-FY '25 to FY '26. - Customer feedback is positive, especially on newly approved products, with some in approval phases. - Some customer destocking observed recently but expected to stabilize with demand recovery. - Marketing and distribution networks for export markets are in progress and expected to be in place by December-January. No concrete order book figures or pending order values are disclosed in the available transcript.